Valter Gattei
Valter Gattei is an expert in Hematology at Centro di Riferimento Oncologico (Italy). As of October 2026, ScienceLeadR ranks Valter Gattei in the top 1% of experts worldwide for Leukemia and Lymphoproliferative Disorders. Valter Gattei has authored 492 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 1,919 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Oncology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1989 - 2026
Number : 492
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition. PMID 42832426 — cells, leukemia, lymphocytic, chronic, b-cell, leukemia, leukemia, lymphoid | Blood | 2026 | 0 |
| A Case of Pseudo-Richter Transformation Following Zanubrutinib Discontinuation in CLL. PMID 42730362 | Mediterr J Hematol Infect Dis | 2026 | 0 |
| Dissecting diffuse large B-cell lymphoma heterogeneity: New insights from a state-specific molecular characterisation. PMID 42613996 — cells, lymphoma, b-cell, ecotype, lymphoma, lymphoma, large b-cell, diffuse, classification, mutation, b-lymphocytes, immune evasion | Clin Transl Med | 2026 | 0 |
| Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience. PMID 42607055 — hematology, safety, neutropenia, immunotherapy, therapeutics, medical oncology | Hematol Oncol | 2026 | 0 |
| The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders. PMID 42588717 — cells, hepatitis c, lymphoma, cryoglobulinemia, rituximab, viruses, satellite viruses, therapeutics, lymphoproliferative disorders, b-lymphocytes, antiviral agents, infections, hepatitis | Cancers (Basel) | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map